Table 5

Markers of Inflammation: CRP & ESR.

Group

Variable

Baseline

4 weeks

8 weeks

Δ 0–4 wks

Δ 0–8 wks

OP

CRP (mg/L)

1.19 ± 0.26

1.02 ± 0.27

1.08 ± 0.25

-0.17 ± 0.2*

-0.11 ± 0.07*

ESR (mm/h)

13.6 ± 2.5

13.5 ± 2.0

13.6 ± 1.7

-0.10 ± 2.4

0.0 ± 2.4

OT

CRP (mg/L)

1.33 ± 0.20

0.95 ± 0.11

0.68 ± 0.14

-0.35 ± 0.2*

-0.62 ± 0.2*

ESR (mm/h)

12.7 ± 0.9

13.0 ± 2.1

12.9 ± 1.6

0.31 ± 2.4

0.38 ± 1.8

NP

CRP (mg/L)

0.76 ± 0.19

0.76 ± 0.19

0.68 ± 0.18

0.04 ± 0.1

-0.08 ± 0.1

ESR (mm/h)

12.5 ± 1.4

12.8 ± 1.7

12.8 ± 1.3

0.30 ± 1.0

0.30 ± 1.1

NT

CRP (mg/L)

1.15 ± 0.22

0.84 ± 0.13

0.64 ± 0.50

-0.31 ± 0.2*

-0.51 ± 0.2*

ESR (mm/h)

13.1 ± 1.2

13.5 ± 1.7

13.3 ± 0.9

0.36 ± 2.5

0.18 ± 1.3

Values at baseline, 4 weeks and 8 weeks are listed as means ± standard deviation. Mean changes (Δ) ± standard deviation after 4 weeks and 8 weeks compared to baseline are listed in the last two columns. A negative value indicates a decrease in value and a positive number represents an increase in value. Values* are significant comparisons (<0.05) based on analysis of variance model results comparing changes from baseline to 4 weeks or 8 weeks. Groups are as follows: OP = overweight/placebo, OT = overweight/treatment, NP = normal weight/placebo and NT = normal weight/treatment.

Oben et al. Nutrition Journal 2009 8:38   doi:10.1186/1475-2891-8-38